Core Insights - The Canadian cannabis sector is evolving with a focus on U.S. market entry and federal reform discussions in the U.S. acting as a catalyst for growth [1][2] - Companies are diversifying into beverages, wellness, and international markets to offset slower growth in Canada, making strong balance sheets and revenue growth increasingly important [2] Company Summaries Tilray Brands Inc. - Tilray is one of the most diversified cannabis companies globally, with a strong presence in Canada and Europe, and has expanded into the U.S. through beverages and wellness products [2][3] - The company operates in over 20 countries with more than 40 brands, primarily gaining U.S. exposure through craft beer and distribution businesses, positioning itself well for potential federal legalization [3][4] - For fiscal 2026, Tilray reported approximately $217 million in quarterly revenue, reflecting modest year-over-year growth, with international cannabis sales increasing and gross profit reaching roughly $57 million [5][6] Canopy Growth Corporation - Canopy Growth is a well-recognized cannabis company with a strong presence in Canada's recreational market and is restructuring operations to improve profitability [7][8] - The company is strategically positioned for U.S. expansion through partnerships with U.S. cannabis operators, although full participation is contingent on federal legalization [8][10] - Canopy has achieved significant cost savings through restructuring, reported a strong cash position, and is moving closer to positive adjusted EBITDA, indicating improving financial health [11][12] Village Farms International, Inc. - Village Farms transitioned from a greenhouse produce grower to cannabis through its Pure Sunfarms brand, focusing on producing low-cost, high-quality products in Canada's retail cannabis market [13][15] - The company has exposure to the U.S. market through hemp-derived CBD operations and is expanding internationally, building a diversified revenue base [15][16] - Financially, Village Farms has shown steady improvement, focusing on increasing margins and controlling expenses, which has strengthened its cannabis segment performance [16][17] Market Outlook - Canadian cannabis stocks are considered speculative but hold potential, largely dependent on U.S. federal reform [17][18] - Tilray stands out for its global diversification and improved financials, Canopy Growth offers a turnaround story with strong liquidity, and Village Farms presents a disciplined, cost-efficient business model [18]

Group 1: Analyst Ratings - Curaleaf has received multiple analyst ratings, with ATB Cormark Capital Markets upgrading it to "outperform" on December 2nd, Alliance Global Partners maintaining a "buy" rating on December 22nd, and Zacks Research upgrading from "strong sell" to "hold" on January 1st [1] - The consensus rating for Curaleaf is "Buy," with two analysts rating it as Strong Buy, one as Buy, and one as Hold [1] Group 2: Financial Metrics - Curaleaf's market capitalization is $1.35 billion, with a P/E ratio of -6.60 and a beta of 0.71 [2][3] - The company has a quick ratio of 0.76, a current ratio of 1.52, and a debt-to-equity ratio of 1.14 [2][3] - The stock has a fifty-day simple moving average of $2.35 and a two-hundred-day simple moving average of $2.60 [2][3] Group 3: Quarterly Earnings - In its latest quarterly earnings report on February 26th, Curaleaf reported earnings per share (EPS) of ($0.05), exceeding the consensus estimate of ($0.08) by $0.03 [4] - The company generated revenue of $333.07 million for the quarter, surpassing the consensus estimate of $328.70 million [4] - Curaleaf has a negative return on equity of 23.17% and a negative net margin of 18.08% [4] Group 4: Company Overview - Curaleaf Holdings, Inc. is a leading American cannabis company involved in the cultivation, processing, and distribution of medical and adult-use cannabis products [5] - The company operates cultivation facilities, processing centers, and retail dispensaries across multiple U.S. jurisdictions, utilizing a vertically integrated model to manage its supply chain [5] - Curaleaf's product portfolio includes premium flower, vaporizer cartridges, edibles, tinctures, topicals, and concentrates [6]

Core Insights - The article discusses the launch and evolution of the 420 Investor service, which began in 2013, coinciding with Colorado's legalization of cannabis for adult use [1] - The service has transitioned to Seeking Alpha, continuing to provide extensive coverage of the cannabis sector, including model portfolios and educational materials for investors [1] - The Amplify Alternative Harvest ETF (MJ) was initially rated as a Sell, and it has since declined by nearly 33%, prompting a reconsideration of its status [1] Company Overview - Alan Brochstein, CFA, is highlighted as a pioneering investment professional in the cannabis industry, starting his career in the securities industry in 1986 [1] - He founded AB Analytical Services in 2007 to offer independent consulting to registered investment advisors and has been managing New Cannabis Ventures since 2015 [1] - The 420 Investor group, which focuses on publicly-traded cannabis stocks, has been operational since 2013 and includes features such as a model portfolio, weekly videos, summaries, and a monthly newsletter [1]

Core Viewpoint - SNDL Inc. is set to release its fourth quarter and full year 2025 financial results on March 12, 2026, before market opening [1] Company Overview - SNDL Inc. is one of the largest vertically integrated cannabis companies in Canada and the largest private-sector liquor and cannabis retailer [2] - The company operates retail banners including Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf [2] - SNDL's consumer-facing cannabis brands include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus, Value Buds, Grasslands, Vacay, Pearls by Grön, No Future, and Bhang Chocolate [2] - The company aims to deploy strategic capital through direct and indirect investments and partnerships in the North American cannabis industry [2]

Core Insights - Village Farms International, Inc. (NASDAQ:VFF) is recognized as one of the best cannabis stocks to invest in currently [1][2] Product Development - The company, through its subsidiary Leli Holland, has launched ten new cannabis product lines in the Netherlands, focusing on consumer insights and operational expertise from global legal cannabis markets [3] - The new product portfolio emphasizes competitive distinctiveness, specific consumption occasions, and innovative formats, tailored to the Dutch legacy market [3] Export Growth - Village Farms has been awarded the 2026 BC Export Awards in the Consumer Products category, reflecting its significant growth in export sales, which increased by 758% year over year as of September 30, 2025 [4] - The company's export operations are supported by EU GMP-certified facilities covering 4.8 million square feet, catering to highly regulated global medical markets [4] Operational Segments - Village Farms operates agricultural greenhouse facilities across the United States and Canada, with key segments including Canadian Cannabis, U.S. Cannabis, Produce, Energy, and Leli [5]

Core Viewpoint - Tilray Brands has significantly underperformed in the market, with a 98% decline in share value over the past five years compared to a 78% increase in the S&P 500 [1] Financial Performance - Tilray reported a net loss of $42 million for the six-month period ending November 30, 2025, an improvement from a $120 million loss in the same period the previous year, attributed to changes in fair value and lower amortization expenses [4] - The company's cash burn improved, using just under $10 million during the six-month period compared to over $76 million a year ago, indicating some progress in financial management [5] Market Outlook - The future of Tilray's stock is uncertain, with concerns that the company's aggressive growth strategy may not yield positive results, especially given the likelihood that U.S. marijuana legalization will not occur soon [6] - There is a prevailing sentiment that Tilray's stock could potentially go to $0 if financial conditions do not improve, particularly if liquidity issues arise [3][6] Investment Considerations - Tilray is viewed as a highly risky investment, with analysts suggesting that there are better and less risky growth stocks available for investors [7]

Industry Overview - The U.S. cannabis sector is adjusting as February 2026 approaches, with a shift in focus towards sustainability and execution rather than rapid expansion [1] - Higher interest rates have prompted companies to reassess spending habits, making balance sheet strength increasingly important [1] - Revenue quality is prioritized over headline growth figures, with companies generating consistent sales standing out [1] Market Dynamics - State-level legalization continues to expand, with several markets maturing into stable revenue generators, providing predictable consumer demand [2] - Medical and adult-use programs are key growth drivers, while federal reform discussions linger as a potential catalyst for the sector [2] - Uncertainty regarding federal reform limits institutional participation in the cannabis market [2] Investor Behavior - Retail investors play a critical role in cannabis trading volume, with February marking renewed interest after year-end repositioning [3] - Tax-loss selling pressure typically fades by February, allowing fundamentally sound stocks to attract attention [3] - Dispensary count and geographic exposure are key evaluation metrics, with diversified operators reducing market-specific risk [3] Financial Discipline - Financial discipline is essential for long-term survival, with companies generating real revenue gaining investor credibility [4] - Companies relying on speculation face increasing pressure, highlighting the importance of operational efficiency and cost management [4] Company Profiles Planet 13 Holdings Inc. (PLNH) - Operates as a vertically integrated cannabis retailer, known for its large Las Vegas dispensary that attracts both tourists and locals [5][6] - Emphasizes experiential retail, blending entertainment and product selection to differentiate from traditional dispensaries [5] - Operates over ten dispensaries nationwide and produces its own cannabis products, targeting premium consumers [6][9] - Revenue has fluctuated due to pricing pressure, but the company continues to generate meaningful quarterly sales [9] - Management focuses on reducing operating expenses and improving margins while monitoring same-store sales trends [10][11] FLUENT Corp. (CNTMF) - Operates as a regional cannabis company with a significant presence in Florida, one of the largest medical cannabis markets [11][12] - Emphasizes controlled expansion and brand consistency, operating over thirty dispensaries nationwide [12][14] - Generates over $100 million in annual revenue, with modest growth affected by pricing pressure [14] - Management focuses on operational efficiency and improving liquidity, with moderate debt levels compared to larger peers [15] Verano Holdings Corp. (VRNOF) - One of the largest cannabis operators in the U.S., with a strong presence in states like Illinois and Florida [16][17] - Operates over 150 dispensaries and owns several cultivation facilities, supporting supply chain control [17][19] - Generates substantial revenue but continues to report net losses due to pricing pressure and elevated operating costs [19] - Management is focused on cost optimization and selective retail expansion, with future profitability dependent on margin recovery [20]

Core Insights - The cannabis industry is evolving with expanding legalization and improving regulations, making cannabis REITs attractive for lower-risk exposure compared to traditional cannabis stocks [1][2] - Cannabis REITs provide predictable cash flow and higher dividend yields, which can stabilize portfolios during market volatility [2] - Heading into Q1 2026, several cannabis REITs are highlighted for their resilience and disciplined capital deployment strategies [3] Industry Overview - Cannabis REITs generate revenue by owning or financing real estate associated with licensed cannabis operators, avoiding direct involvement in cannabis production or sales [1] - The focus on long-term leases and structured financing agreements allows these REITs to benefit from stable income streams [1][2] Key Companies to Watch - **Innovative Industrial Properties, Inc. (IIPR)**: A pioneer in the cannabis REIT space, focusing on specialized properties for cultivation and processing, with a national footprint across 19 states [6][7] - **NewLake Capital Partners, Inc. (NLCP)**: Engages in sale-leaseback transactions and build-to-suit projects, owning both dispensary and production properties, emphasizing disciplined underwriting [11][12] - **Chicago Atlantic Real Estate Finance, Inc. (REFI)**: Focuses on senior secured lending to licensed cannabis operators, generating income through interest rather than rent [14][15] Financial Performance - IIPR has a strong balance sheet with resilient revenue, supporting reliable dividend payments despite sector volatility [10][11] - NewLake has demonstrated steady revenue growth and consistent profitability, appealing to income investors [13][14] - REFI is known for its high dividend yield and robust cash flow, maintaining reasonable leverage and sufficient liquidity for ongoing lending [18][19] Market Positioning - Cannabis REITs are positioned to benefit from potential federal reforms that could improve tenant profitability and credit quality, indirectly enhancing their performance [4] - The focus on established operators with operational history helps reduce tenant default risk across these REITs [9][12]

Core Viewpoint - The AdvisorShares Pure Cannabis ETF (YOLO) is an actively managed exchange-traded fund aimed at providing investors with global exposure to the cannabis industry [1] Group 1: Fund Overview - YOLO is designed to invest in companies operating within the cannabis sector on a global scale [1] Group 2: Analyst Background - Michael Del Monte is a buy-side equity analyst with over a decade of experience in various sectors including technology, energy, and industrials [1]

Core Viewpoint - The AdvisorShares Pure Cannabis ETF (YOLO US) aims for long-term capital appreciation by focusing on cannabis-related equities and derivatives while adhering to cannabis laws [1] Investment Strategy - The ETF invests at least 80% of net assets in issuers that derive 50% or more of their revenue from marijuana or hemp businesses, including derivatives with similar economic exposure [1] - The portfolio primarily includes mid- and small-cap common and preferred stocks, an affiliated US-focused cannabis ETF, and total return swaps referencing cannabis equities [1] - The investable universe encompasses sectors such as agriculture, biotechnology, pharmaceuticals, real estate, retail, and financial services, along with firms expected to generate future cannabis-related revenues or DEA-registered companies conducting lawful cannabinoid research [1] Portfolio Construction - The portfolio is non-diversified and concentrates at least 25% in the pharmaceuticals, biotechnology, and life sciences industry group [1] - Selection is driven by research tools and a bottom-up assessment of market position, growth potential, and valuation, while selling decisions are based on relative opportunity or position-size limits [1]